# Measles + Mumps + Rubella

## Priorix inj (MMR) 0.5 mL/dose (Private)

| TAH Drug Code      | [IMMR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMMR)                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Immunization against measles, mumps & rubella in individuals ≧ 12 months, non-pregnant adolescents, adult female & postpartum women. Children ≦12 months, should be revaccinated after reaching 15 months.                                                                                                                                                                         |
| Dosing             | SC, 0.5mL, children 6-12 months primary immunization, the 2nd dose at 15 months of age, the 3rd dose at 4-6 years or 11-12 years. Age > or = 12 months primary immunization, the 2nd dose at 4-6 years or 11-12 years.                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Pregnancy. Any febrile infection or febrile respiratory illness. Active untreated TB, blood dyscrasias, leukemia, lymphomas of any type, malignant neoplasms affecting the bone marrow or lymphatic system. Patients receiving immunosuppressive therapy. Primary & acquired immunodeficiency states, or family history of immunodeficiency. Hypersensitivity to neomycin or eggs. |
| Adverse Effects    | Burning, stinging at inj site. Headache, fever, sore throat, GI upset, rash, arthralgia &/or arthritis, parotitis, nerve deafness, optic neuritis. Lymphadenopathy, afebrile convulsions, ataxia, Guillain-Barre syndrome, thrombocytopenia purpura, dizziness, paraesthesias.                                                                                                     |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                      |

## Priorix (Government) 0.5mL/dose

| TAH Drug Code      | [IMMR1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMMR1)                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Immunization against measles, mumps & rubella in individuals ≧ 12 months, non-pregnant adolescents, adult female & postpartum women. Children ≦12 months, should be revaccinated after reaching 15 months.                                                                                                                                                                         |
| Dosing             | SC, 0.5mL, children 6-12 months primary immunization, the 2nd dose at 15 months of age, the 3rd dose at 4-6 years or 11-12 years. Age > or = 12 months primary immunization, the 2nd dose at 4-6 years or 11-12 years.                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Pregnancy. Any febrile infection or febrile respiratory illness. Active untreated TB, blood dyscrasias, leukemia, lymphomas of any type, malignant neoplasms affecting the bone marrow or lymphatic system. Patients receiving immunosuppressive therapy. Primary & acquired immunodeficiency states, or family history of immunodeficiency. Hypersensitivity to neomycin or eggs. |
| Adverse Effects    | Burning, stinging at inj site. Headache, fever, sore throat, GI upset, rash, arthralgia &/or arthritis, parotitis, nerve deafness, optic neuritis. Lymphadenopathy, afebrile convulsions, ataxia, Guillain-Barre syndrome, thrombocytopenia purpura, dizziness, paraesthesias.                                                                                                     |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                      |

